Company
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| VIR-5818 | Phase 1/2 | Locally Advanced or Metastatic HER2-Expressing Cancers |
Latest
No recent events.
Follow Vir Biotechnology, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.